Search Results

Discovery challenges a long-held belief in RNA editing and opens a promising new avenue for cancer immunotherapy.

New research suggests a small group of pediatric brain tumor patients may benefit from immunotherapy.

SARS-CoV-2 may dramatically impair the immune response by reprogramming neutrophils resulting in severe covid.

Researchers develop antibody therapy to target cancer by focusing on the tumour environment, showing promise for wider cancer treatment applications

The trial pause affects rap-cel studies for autoimmune and neurological diseases, while Novartis continues investigating the CAR-T therapy in cancer

CAR-T therapy shows early promise against recurrent glioblastoma.